IMMUNEERING CORPORATIO
2.0500
26-11月-24 16:45:00
15 分の遅延
株式
-0.0300
-1.44%
本日の幅
2.0300 - 2.1100
ISIN
N/A
ソース
NASDAQ
-
Immuneering Announces Participation in March Investor Conferences
24 2 2022 06:50:00 提供 Nasdaq GlobeNewswire
-
Immuneering Announces Participation in Upcoming Investor Conferences
24 1 2022 06:50:00 提供 Nasdaq GlobeNewswire
-
Immuneering Strengthens Board of Directors with the Appointment of Diana F. Hausman, M.D.
18 1 2022 06:50:00 提供 Nasdaq GlobeNewswire
-
06 1 2022 16:10:00 提供 Nasdaq GlobeNewswire
-
Immuneering Appoints Rimma Steinhertz, Ph.D., PMP as Vice President, Project and Alliance Management
03 1 2022 06:50:00 提供 Nasdaq GlobeNewswire
-
Immuneering Added to the Nasdaq Biotechnology Index
16 12 2021 06:50:00 提供 Nasdaq GlobeNewswire
-
Immuneering Announces Participation in December Investor Conferences
18 11 2021 06:35:00 提供 Nasdaq GlobeNewswire
-
Immuneering to Participate in Jefferies 2021 London Healthcare Conference
10 11 2021 06:50:00 提供 Nasdaq GlobeNewswire
-
Immuneering Reports Third Quarter 2021 Financial Results and Recent Business Highlights
09 11 2021 06:30:00 提供 Nasdaq GlobeNewswire
-
11 10 2021 06:50:00 提供 Nasdaq GlobeNewswire
-
01 10 2021 06:50:00 提供 Nasdaq GlobeNewswire
-
Immuneering Announces Inclusion in the Russell 2000® Index
20 9 2021 16:10:00 提供 Nasdaq GlobeNewswire
-
Immuneering Reports Second Quarter 2021 Financial Results and Provides Business Updates
09 9 2021 06:30:00 提供 Nasdaq GlobeNewswire
-
Immuneering to Participate in September Investor Conferences
02 9 2021 16:05:00 提供 Nasdaq GlobeNewswire
-
03 8 2021 16:07:00 提供 Nasdaq GlobeNewswire
-
Immuneering Announces Pricing of Upsized Initial Public Offering
29 7 2021 22:47:58 提供 Nasdaq GlobeNewswire